1. Home
  2. SYM vs RGEN Comparison

SYM vs RGEN Comparison

Compare SYM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Symbotic Inc.

SYM

Symbotic Inc.

HOLD

Current Price

$49.65

Market Cap

7.5B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$110.95

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYM
RGEN
Founded
2005
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
6.6B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
SYM
RGEN
Price
$49.65
$110.95
Analyst Decision
Buy
Buy
Analyst Count
12
12
Target Price
$62.50
$167.67
AVG Volume (30 Days)
1.6M
1.3M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
0.03
0.15
Revenue
$2,246,922,000.00
$141,236,000.00
Revenue This Year
$24.75
$14.30
Revenue Next Year
$27.90
$14.52
P/E Ratio
$1,558.17
$724.87
Revenue Growth
25.65
35.10
52 Week Low
$26.70
$100.99
52 Week High
$87.88
$175.77

Technical Indicators

Market Signals
Indicator
SYM
RGEN
Relative Strength Index (RSI) 40.82 43.94
Support Level $49.39 N/A
Resistance Level $50.14 $129.77
Average True Range (ATR) 3.19 6.03
MACD -1.04 -1.08
Stochastic Oscillator 28.66 32.66

Price Performance

Historical Comparison
SYM
RGEN

About SYM Symbotic Inc.

Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: